Introduction
The introduction of the microarrays, next-generation sequencing and other high-throughput biotechnologies has enabled the biomedical research community the opportunity to quickly and economically collect data on the entire genome, epigenome, transcriptome and proteome of multiple tissue samples. This enormous data collection capacity offers the exciting potential to accelerate biological discovery in unprecedented ways. However, an intrinsic element of this opportunity is the daunting challenge of how to effectively and correctly interpret these mountains of data. The magnitude of the data sets presents computational challenges of data handling and storage and the statistical challenges of analysis and interpretation. Many data analysis methods were proposed to meet these challenges.
However, some oversights occurred during the sprint in development of analysis methods to capitalise on these new opportunities. Some study results appeared to be revolutionary breakthroughs but were eventually determined to be due to technical artefacts and poor experimental design 1 . Also, some data analysis methods were widely adopted because they were used in high-impact publications and were freely available in robust easy-touse software implementations but have a poor epistemological basis. In this way, poor experimental design and data analysis have introduced an abundance of nonsense into the 'omics' literature. Thus, it is important to be able to recognise, resolve and prevent such nonsense in future research involving high-throughput data collection. Here, three forms of nonsense and strategies to address them are described.
Confounded experiments
Experimental design profoundly impacts the strengths and limitations of a scientific study. A robust design can greatly enhance the reliability of a study's results; conversely, a faulty design can severely diminish the value of a study. The experimental design permeates every component of a scientific investigation. The experimental design dictates the collection of data which subsequently guides the analysis and interpretation of that data. Once the study is completed, the experimental design and execution become an unalterable and intrinsic feature of the data set. Thus, it is important to design and execute an experiment provide the data a heritage that enhances the legacy of the study.
It is important that experimental designs proactively address the potential impact of technical factors on the data collection process. Modern high-throughput data collection technologies require the execution of complex laboratory protocols that typically involve multiple procedures such as storage of tissue specimens, extraction of molecular material, preparation of molecular material Therefore, it is absolutely imperative that the experimental design provide a way to unambiguously distinguish technical effects from biological effects. One of the most devastating experimental design practices is to confound technical and biological factors ( Figure 1A ). Confounding occurs when most observations of one biological condition are collected under one set of technical conditions while most observations of another biological condition are collected under a different set of technical conditions. In such a setting, the mathematical form of a statistical comparison of biological conditions will be very similar to the mathematical form of a statistical comparison of technical conditions. Thus, it is not possible to unambiguously attribute a statistically significant difference to either the biological or technical factors that define those conditions ( Figure 1B ). For example, a proteomic biomarker that appeared to be a highly sensitive and specific screen for ovarian cancer is now believed to be a technical artefact due to an undocumented modification of laboratory procedures 1 . This shows that it is possible for technical effects to overwhelm biological effects and produce false leads.
Confounding in a published study may be recognised by extracting the date from low-level data files that are posted in public data repositories such as the gene expression omnibus. For example, Affymetrix CEL files give the hybridisation florescence intensity of each physical coordinate on the microarray. The date stamps within these files indicate when the file was generated by scanning the array. Thus, these date stamps may be used to infer which arrays were processed together in the same technical batch.
A popular but inadequate experimental strategy to provide a way to ascertain technical effects is to include a control sample in each technical setting (or batch). For example, in their study of hematopoietic cell lineages, Novershtern et al. 2 included the Hela cell line in each of their technical batches. They then applied a method which uses analysis of variance (ANOVA)-style modelling to estimate and remove batch effects from the comparison across cell lineages for each gene. With this experimental design, it is clearly impossible for an ANOVA model to obtain meaningful estimates of the technical effects for each gene that is unexpressed in the Hela cell line. Also, estimating and adjusting for technical effects may be problematic for genes that are expressed in the Hela cell line but not expressed in one or more of the hematopoietic cell lineages.
There are many well-established experimental design practices that ensure there is a statistically robust way to estimate and adjust for technical factors in the final analysis. There are many well-established experimental designs (with associated statistical analysis procedures) that balance the representation of biological conditions within technical batches and theoretically provide a straightforward way to obtain unbiased estimates for important biological effects ( Figure 1C ,D). These are described in experimental design textbooks such as Hinkelmann and Kempthorne 3 and Kuehl 4 .
Pre-processing de ines uninterpretable variables
Due to the technical issues described above, it is often necessary to perform some normalisation and other pre-processing to prepare data for statistical analyses that address the biological questions of interest. Soon after the introduction of microarray technology, a flood of pre-processing and normalisation algorithms were published. Some normalisation methods were purely algorithmic with little or no supporting statistical rationale provided while others had elaborate statistical models with terms for very specific technical and biological factors 5, 6 . So many preprocessing and normalisation methods were published that the editorial board of Bioinformatics issued a formal policy statement to set standards for the publication of any additional normalisation methods 7 . Methods that were included in microarray manufacturer software or that performed well in a few simple spikein studies were rapidly adopted by most of the bioinformatics community while the other methods were promptly forgotten.
Prior to the advent of microarray technology, gene expression was measured with real-time polymerase chain reaction and explicitly represented in relative terms. Gene expression was represented as the abundance of the gene of study relative to a housekeeping gene such as glyceraldehyde-3-phosphate dehydrogenase. Microarray gene expression data was simply termed 'expression' without considering whether any more detailed definition of 'expression' existed or was necessary. Some normalisation methods, such as mean-centering or meanscaling, produced expression values that represented hybridisation intensity of a specific gene relative to the mean hybridisation intensity of all genes. However, other methods perform so many complex computational operations that it is difficult, if not impossible, to provide a formal definition of what the normalised 'expression' values quantitatively represent. As such, the role of preprocessing in defining the variable for subsequent statistical analysis was largely overlooked.
The introduction of singlenucleotide polymorphism (SNP) microarrays and their use to identify copy number abnormalities in tumours exposed these epistemological flaws of widely used normalisation procedures. Tumour genomes are extremely unstable and frequently exhibit gross aneuploidy.
In this setting, many normalisation methods implicitly represent hybridisation intensities relative to a parameter that is not constant across all tumours. For instance, the mean hybridisation intensity for one tumour may represent 2.5 copies while the mean hybridisation intensity for another tumour may represent 1.5 copies because the first tumour had a hyperdiploid genome while the second tumour's genome was hypodiploid. Mullighan et al. 8 and Pounds et al. 9 noted that it was imperative that normalisation represent SNP microarray hybridisation intensities relative to those of a reference panel of markers that were in the two-copy state. In this way, the biological meaning of the normalised data values was the same across all tumours and the accuracy of the final copy number results determined by comparison with cytogenetic data dramatically improved (Figure 2) . Therefore, Mullighan and Downing 10 stated that normalizing their data relative to an appropriate reference was 'critical' for accurate copy number analysis of tumour genomes. There are several effective strategies to recognise that a normalisation procedure computationally defines a variable without a meaningful biological interpretation. First, one should attempt to write a concise quantitative definition of the normalised variable that is noncircular (e.g., the normalised value represents 'expression' of the gene). Difficultly in completing this exercise may indicate that correct biological interpretation of subsequent statistical analysis results will be problematic. Secondly, presuming that it is possible to assign a biologically meaningful quantitative definition to the normalised variable, one should evaluate the consistency of the data and statistical analysis results with that definition. For example, if the implicit reference of normalisation is the entire genome (as is the case for mean-centering or quantile normalisation), then identification of a large number of differentially expressed genes indicates that a large portion of the genome does not have constant expression across all biological conditions. In this case, the normalisation reference is not constant across the experiment and hence the normalised data value does not have the same biological meaning across the experiment which implies that subsequent statistical comparisons are uninterpretable.
Preventing these normalisation problems requires careful evaluation of existing normalisation procedures to determine the appropriateness of its reference parameter, the definition of the variable it computes, and adequacy of other assumptions it makes in the context of the particular biological application. This careful epistemological evaluation can help guide the selection of an existing normalisation procedure or the development and justification of a custom normalisation procedure. As previously noted, this perspective was absent from most of the early normalisation literature. Thus, there is an opportunity to explore these topics and propose effective solutions for multiple technologies and experimental settings.
Data analysis methods that ignore experimental design and other biological realities
As statistical analyses of microarray gene expression data began producing extensive lists of genes that were associated with various phenotypes across a spectrum of biological settings, it became clear that the biological interpretation of these results would be enhanced by determining whether the differentially expressed genes represented a particular pathway or process. Addressing this question required more thorough integration of annotations describing gene functions into the data analysis. Initial attempts to this applied statistical methods designed for contingency table analysis of subjects to contingency tables of genes. For example, these approaches would apply the χ2 test or Fisher's test to a crosstabulation of an indicator of genes' inferred differential expression status with an indicator of whether they were annotated to a specific biological function or process. Some high-impact publications used this method; subsequently, this computationally simple procedure was implemented in several user-friendly software packages. Now, the general approach is almost ubiquitous in the literature.
Such prevalent misapplication of cross-tabulation methods across a broad spectrum of experimental settings is possible because it has no connection to the experimental design. The cross-tabulation of genes requires no information regarding the sample size, the phenotype, treatment allocations, or other aspects of experimental design. The analysis is based on a simple hyper-geometric model that represents the experiment as a lottery-style selection of genes from an urn. This is mathematically equivalent to permuting the assignment of genes' annotation labels to their statistical inference results. In the cross-tabulation, the statistical analysis results are fixed. Thus, the cross-tabulation of genes computationally mimics the biologically impossible series of experiments such that each experiment has a set of subjects with genes whose function is determined by a random permutation that remarkably happens to be identical for all subjects in that experiment but this permutation of gene function differs from experiment to experiment ( Figure 3A,B) . The computationally modelled series of experiments is statistically impossible in that each experiment yields exactly the same quantitative results for the association of genes with phenotypes. Thus, gene cross-tabulation is implicitly based on a computational model that is biologically and statistically impossible. Another biologically impossible data analysis model for this problem permutes both the assignment of subject phenotype data to subject genomic data and the assignment of genes to their annotations ( Figure 3C ).
The problem of ignoring the experimental design can be easily recognised. Usually, reading the published description of the analysis method will reveal whether it uses a model that represents the experimental design in its calculations. However, sometimes a simple reading does not clarify whether the method uses the experimental design or not because it is quite rare to explicitly admit that a data analysis ignored the experimental design. Using the software will totally illuminate the issue. Any software that does not require inputting experimental design details to generate analysis results obviously ignores the experimental design.
Thankfully, the problem of ignoring experimental design may be addressed by using methods that incorporate experimental design into their computational models. use statistical models that explicitly use details of the experimental design 11, 12, 13 . These methods perform the statistical analysis of the association of genes with the phenotype and then summarise the statistical significance results according to gene annotation. This entire analysis procedure is repeated for each of many data sets that are computationally generated by permuting the assignment of subjects' phenotype data to their genomic data ( Figure 3D ). The computational model is biologically realistic in that genes functions and correlations to one another are retained. It is also statistically realistic in that each distinct permutation of the data set yields a quantitatively distinct set of data analysis results. Each analysis of one of these computationally generated data sets yields results that may be obtained from an identically designed experiment in which the genes' function is the same but the subjects' phenotypes have no association with any feature of the subjects' genomes. This has classically been the null hypothesis of greatest scientific meaning and interest.
Discussion
New biotechnologies have proven to be useful tools to advance biological discovery and understanding. However, some oversights in experimental design and statistical analysis have produced only mirages of progress that ultimately proved to be very disappointing. The scientific community desperately needs to recognise and avoid mistakes of the past to preserve its own credibility and increase public confidence in research. It is important to avoid using confounded experimental designs that unnecessarily leave studies exposed to the possibility of mistaking strong technical effects for revolutionary biological discovery and subsequent misallocation of many years of research effort and resources. It is equally imperative to recognise that some widely used data analysis programs may produce biologically meaningless data or statistically test biologically meaningless hypotheses. Thus, researchers should enthusiastically welcome the incorporation of rigorous statistical considerations into the planning, design, execution and interpretation of ambitious 'big data' studies as an indispensible investment in the efficiency of their overall research program.
It is very easy to avoid two of the three forms of nonsense described. Poor experimental designs can be avoided by investing a few additional planning hours into a research project that typically takes months to years to complete. Also, several statistical analysis methods that appropriately model the experimental design in the analysis are available for most experimental designs. Many of these analysis methods are available as R packages. For instance, there are several methods that consider the experimental design in testing the association the phenotype with a set of genes with a common biological annotation.
Future research should help develop ways to avoid the nonsense of pre-processing methods empirically defining biologically meaningless variables. This is perhaps the most pervasive and widely accepted potential source of nonsense in computational biology. Such research should philosophically determine what biological measurement that pre-process should seek to produce and articulate specific assumptions to guide the development of pre-processing procedures that produce a reasonable approximation of that measurement. This will help the field to mature in both theoretical and practical dimensions. 
Conclusion
There should be a systematic effort to evaluate and make necessary corrections to the epistemological basis of widely used data analysis methods in computational biology. Some potential topics would include exploring ways to construct subject-specific reference genomes to improve the accuracy of nucleotide sequence mapping (because a particular subject's or tumour's genome inevitably differs from the reference human genome in interesting ways that may be missed because the sequence that reveal such variation are not mapped), identifying a reliable reference to normalise gene expression data (as described above), and exploring the impact of the order of data analysis tasks in a pipeline (it seems that the field has accepted that some tasks should be done in a specific order without questioning whether alternative orders of those tasks may be statistically more reliable).
